Multiple factors including the viability of the primary tumor sample, the sterility of the tumor handling and the genetic mutation status (such as Smad4 loss) determine successful engraftment of patient tumor tissue following xenotransplantation into immunodeficient mice [24,31,32]. Here, SMAD4 is linked to neoplasm.